Is administering 1gm of intravenous (IV) magnesium sulfate appropriate for a patient with dengue fever and hypomagnesemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Intravenous Magnesium Sulfate 1g is Appropriate for Hypomagnesemia in Dengue Fever

For a patient with dengue fever and hypomagnesemia, administering 1g of intravenous magnesium sulfate is appropriate and aligns with current guidelines. 1, 2

Dosing Guidelines for Hypomagnesemia

  • For mild magnesium deficiency, the standard adult dose is 1g of magnesium sulfate IV, which is equivalent to 8.12 mEq of magnesium 2
  • The American Heart Association recommends administering 1-2g IV over 15 minutes for acute hypomagnesemia 3
  • For severe hypomagnesemia, up to 250mg/kg body weight may be given, or alternatively, 5g can be added to IV fluids for slow infusion over three hours 2
  • Magnesium replacement is specifically recommended for the management of hypomagnesemia [Level V, C evidence] 1

Administration Technique

  • IV solutions must be diluted to a concentration of 20% or less prior to administration 2
  • The rate of IV injection should generally not exceed 150 mg/minute 2
  • Common diluents include 5% Dextrose Injection and 0.9% Sodium Chloride Injection 2
  • Maintenance therapy should be titrated based on serum magnesium levels, with a target range of 1.3-2.2 mEq/L 3

Monitoring and Precautions

  • Monitor serum magnesium levels and clinical status to avoid overdosage 2
  • Clinical indicators of safe dosing include presence of patellar reflex and adequate respiratory function (≥16 breaths/min) 2
  • Have calcium immediately available to counteract potential magnesium toxicity 3, 2
  • Use with caution in patients with renal impairment as magnesium is eliminated solely by the kidneys 2
  • Ensure urine output is maintained at ≥100 mL during the four hours preceding each dose 2

Specific Considerations for Dengue Fever

  • Hypomagnesemia is a recognized complication in dengue fever that requires correction 4
  • Correction of hypomagnesemia is crucial to avoid refractory hypokalemia, which can lead to severe consequences in dengue patients 4
  • Hypomagnesemia may manifest with neuromuscular symptoms including irritability, nystagmus, seizures, contractures, and severe pain 1
  • IV magnesium sulfate replacement can effectively reverse these symptoms 1

Drug Interactions

  • Use with caution when administering with CNS depressants, as magnesium has additive CNS depressant effects 2
  • Exercise extreme caution in digitalized patients, as serious changes in cardiac conduction may occur if calcium administration becomes necessary 2
  • Be cautious with concurrent neuromuscular blocking agents due to risk of excessive neuromuscular block 2

In conclusion, 1g of IV magnesium sulfate is an appropriate dose for treating hypomagnesemia in a patient with dengue fever. This dose aligns with FDA-approved dosing guidelines and clinical recommendations for mild to moderate hypomagnesemia.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Magnesium Sulfate Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

An unusual case of dengue infection presenting with hypokalemic paralysis with hypomagnesemia.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.